These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 2516609

  • 1. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA, Verberckmoes R, Michielsen P, Koene RA.
    Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
    [Abstract] [Full Text] [Related]

  • 2. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.
    Yagil Y.
    Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C, Blumberg A.
    Schweiz Med Wochenschr; 1990 Feb 17; 120(7):217-20. PubMed ID: 2309110
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Seizures in haemodialysis patients treated with recombinant human erythropoietin.
    Edmunds ME, Walls J, Tucker B, Baker LR, Tomson CR, Ward M, Cunningham J, Moore R, Winearls CG.
    Nephrol Dial Transplant; 1989 Feb 17; 4(12):1065-9. PubMed ID: 2517327
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD, James KM, Levy JK, Browne JK, Miller A, Lobingier RT, Egrie JC.
    J Am Vet Med Assoc; 1998 Feb 15; 212(4):521-8. PubMed ID: 9491159
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
    Jacquot C, Berthelot JM, Chiappini-Judith D, Ferragu-Haguet M, Lefebvre A, Masselot JP, Moynot A, Frydman MO, Peterlongo F.
    Nephrologie; 1990 Feb 15; 11(1):11-6. PubMed ID: 2374641
    [Abstract] [Full Text] [Related]

  • 10. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H, Mayer G, Cada EM, Thum J, Stummvoll HK.
    Wien Klin Wochenschr; 1987 Dec 18; 99(24):855-9. PubMed ID: 3439185
    [Abstract] [Full Text] [Related]

  • 11. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).
    Roger SD, Baker LR, Raine AE.
    Clin Nephrol; 1993 Feb 18; 39(2):103-10. PubMed ID: 8448912
    [Abstract] [Full Text] [Related]

  • 12. [The treatment of anemia in patients on hemodialysis with recombinant human erythropoietin].
    Borrego FJ, Miguel JL, Zamorano A, Muñoz J, Bajo A, López-Revuelta K, Sánchez Sicilia L.
    Med Clin (Barc); 1991 Nov 23; 97(18):687-92. PubMed ID: 1770818
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM, Kürner B, Zech M, Krahn R, Heidland A.
    Dtsch Med Wochenschr; 1988 Jan 29; 113(4):125-9. PubMed ID: 3276487
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT, Prata MM, Barbas JV, dos Santos JP.
    Acta Med Port; 1990 Jan 29; 3(6):347-52. PubMed ID: 2089856
    [Abstract] [Full Text] [Related]

  • 15. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC, BA 16528 Study Investigators.
    Clin Nephrol; 2007 May 29; 67(5):306-17. PubMed ID: 17542340
    [Abstract] [Full Text] [Related]

  • 16. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A, Barrau J, Gómez Alamillo C, Jaurrieta F.
    Sangre (Barc); 1990 Feb 29; 35(1):82-4. PubMed ID: 2333585
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP, Abels RI, McNeill MV, Sullivan DJ.
    Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar 13; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.